Literature DB >> 1646175

Laminin receptors, collagenase IV and prognosis in node-negative breast cancers.

M G Daidone1, R Silvestrini, A D'Errico, G Di Fronzo, E Benini, A M Mancini, S Garbisa, L A Liotta, W F Grigioni.   

Abstract

In 187 node-negative breast cancers, the expression of laminin receptors and collagenase IV was directly related in 52% of cases, independently of pathological (tumor size and histology) and biological (estrogen receptors and proliferative activity) features. Moreover, the presence of laminin receptors and collagenase IV did not appear to influence tumor proliferative activity, evaluated as 3H-thymidine labelling index. In this case series, relapse-free survival and overall survival at 6 years were significantly affected by tumor size, hormone receptor status and proliferative activity. Conversely, high levels of laminin receptors and collagenase IV failed to influence relapse-free or overall survival, whereas they were strong indicators of local-regional diffusion of the disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1646175     DOI: 10.1002/ijc.2910480409

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  29 in total

1.  Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression.

Authors:  S Martignone; R Pellegrini; E Villa; N N Tandon; A Mastroianni; E Tagliabue; S Ménard; M I Colnaghi
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

2.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

Review 3.  Matrix metalloproteinase inhibitors: present achievements and future prospects.

Authors:  L J Denis; J Verweij
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

4.  Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth.

Authors:  Annette Lebeau; Claudia Müller-Aufdemkamp; Clarissa Allmacher; Ulrich Sauer; Andreas Nerlich; Ralf Lichtinghagen; Udo Löhrs
Journal:  J Mol Histol       Date:  2004-06       Impact factor: 2.611

5.  Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis.

Authors:  P Lipponen; H Ji; S Aaltomaa; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

6.  Prognostic significance of laminin production in relation with its receptor expression in human breast carcinomas.

Authors:  R Pellegrini; S Martignone; E Tagliabue; D Belotti; R Bufalino; N Cascinelli; S Ménard; M I Colnaghi
Journal:  Breast Cancer Res Treat       Date:  1995-08       Impact factor: 4.872

7.  MT-MMP expression and localisation in human lung and breast cancers.

Authors:  M Polette; B Nawrocki; C Gilles; H Sato; M Seiki; J M Tournier; P Birembaut
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

8.  Oncogene-induced basement membrane invasiveness in human mammary epithelial cells.

Authors:  E W Thompson; J Torri; M Sabol; C L Sommers; S Byers; E M Valverius; G R Martin; M E Lippman; M R Stampfer; R B Dickson
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

9.  Quantitative immunohistochemical determination of cathepsin-D and its relation with other variables.

Authors:  S Veneroni; M G Daidone; G Di Fronzo; V Cappelletti; D Amadori; A Riccobon; A Paradiso; M Correale; R Silvestrini
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

10.  Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma.

Authors:  Vered Givant-Horwitz; Ben Davidson; Gregg van de Putte; Hiep Phuc Dong; Iris Goldberg; Sivan Amir; Gunnar B Kristensen; Reuven Reich
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.